Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial.
Conte, Michael S
Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. [electronic resource] - Journal of vascular surgery Sep 2005 - 456-64; discussion 464-5 p. digital
Publication Type: Journal Article
0741-5214
10.1016/j.jvs.2005.05.001 doi
Aged
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Blood Vessel Prosthesis
Cardiotonic Agents--therapeutic use
Chi-Square Distribution
Clinical Trials, Phase III as Topic
DNA--therapeutic use
Double-Blind Method
Female
Graft Occlusion, Vascular--prevention & control
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Inguinal Canal--blood supply
Ischemia--drug therapy
Leg--blood supply
Limb Salvage--methods
Male
Middle Aged
Multicenter Studies as Topic
Multivariate Analysis
Oligonucleotides
Peripheral Vascular Diseases--drug therapy
Platelet Aggregation Inhibitors--therapeutic use
Prospective Studies
Randomized Controlled Trials as Topic
Risk Factors
Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. [electronic resource] - Journal of vascular surgery Sep 2005 - 456-64; discussion 464-5 p. digital
Publication Type: Journal Article
0741-5214
10.1016/j.jvs.2005.05.001 doi
Aged
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Blood Vessel Prosthesis
Cardiotonic Agents--therapeutic use
Chi-Square Distribution
Clinical Trials, Phase III as Topic
DNA--therapeutic use
Double-Blind Method
Female
Graft Occlusion, Vascular--prevention & control
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Inguinal Canal--blood supply
Ischemia--drug therapy
Leg--blood supply
Limb Salvage--methods
Male
Middle Aged
Multicenter Studies as Topic
Multivariate Analysis
Oligonucleotides
Peripheral Vascular Diseases--drug therapy
Platelet Aggregation Inhibitors--therapeutic use
Prospective Studies
Randomized Controlled Trials as Topic
Risk Factors